These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9621152)

  • 41. Anti-nuclear antibodies as predictor of outcome in a multi-center cohort of Italian children and adolescents with Raynaud's phenomenon.
    Falcini F; Rigante D; Candelli M; Martini G; Corona F; Petaccia A; La Torre F; Raffaele CG; Matucci Cerinic M
    Clin Rheumatol; 2015 Jan; 34(1):167-9. PubMed ID: 25428518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

  • 43. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of vorinostat in combination with interferon alpha and extracorporeal photopheresis in late stage mycosis fungoides and Sezary syndrome.
    Sanli H; Akay BN; Anadolu R; Ozcan M; Saral S; Akyol A
    J Drugs Dermatol; 2011 Apr; 10(4):403-8. PubMed ID: 21455551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant pheochromocytoma associated with Jaccoud's-type arthropathy, Raynaud's phenomenon, positive antinuclear antibody and rheumatoid factor.
    Tsai JJ; Tsai WJ; Yen JH; Chen JR; Lin SF; Liu HW
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Sep; 10(9):518-21. PubMed ID: 7983696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neck pain and fever after peginterferon alpha-2a].
    Moser C; Furrer J; Ruggieri F
    Praxis (Bern 1994); 2007 Feb; 96(6):205-7. PubMed ID: 17330412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nomenclature of Raynaud's phenomenon: a capillary microscopic and hemorheologic study.
    Jacobs MJ; Breslau PJ; Slaaf DW; Reneman RS; Lemmens JA
    Surgery; 1987 Feb; 101(2):136-45. PubMed ID: 3810484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.
    Kuzel TM; Roenigk HH; Samuelson E; Herrmann JJ; Hurria A; Rademaker AW; Rosen ST
    J Clin Oncol; 1995 Jan; 13(1):257-63. PubMed ID: 7799028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Results of photochemotherapy in a series of 47 patients with mycosis fungoides].
    Piccinno R; Caccialanza M; Mainardi L
    G Ital Dermatol Venereol; 1989; 124(7-8):369-73. PubMed ID: 2628282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoid dermatitis mimicking progression in mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Group.
    Molin L; Thomsen K; Volden G; Lange Wantzin G
    Acta Derm Venereol; 1985; 65(1):69-71. PubMed ID: 2578710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual variants of mycosis fungoides.
    Abeldaño A; Arias M; Benedetti A; Ochoa K; Maskin M; Pellerano G; Kien MC; Chouela E
    Skinmed; 2011; 9(4):218-22. PubMed ID: 21980706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
    Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
    Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient lymphomatoid papulosis in mycosis fungoides.
    Aronsson A; Jonsson N; Tegner E
    Acta Derm Venereol; 1982; 62(6):529-31. PubMed ID: 6187163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of mycosis fungoides with imiquimod 5% cream.
    Ariffin N; Khorshid M
    Clin Exp Dermatol; 2006 Nov; 31(6):822-3. PubMed ID: 17040269
    [No Abstract]   [Full Text] [Related]  

  • 57. [Mycosis fungoides terminating in acute myelocytic leukemia].
    Takeoka Y; Yamane T; Koh KR; Ohta K; Nakamae H; Aoyama Y; Hirose A; Fujino Y; Inoue T; Hino M; Tatsumi N
    Rinsho Ketsueki; 2000 Sep; 41(9):755-60. PubMed ID: 11070939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithyroid hormone antibodies induced by interferon-alpha.
    Papo T; Oksenhendler E; Izembart M; Leger A; Clauvel JP
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1484-6. PubMed ID: 1464652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycosis fungoides: the addition of concurrent and adjuvant interferon to total skin electron beam therapy.
    Wagner AE; Wada D; Bowen G; Gaffney DK
    Br J Dermatol; 2013 Sep; 169(3):715-8. PubMed ID: 23600444
    [No Abstract]   [Full Text] [Related]  

  • 60. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L
    Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.